dc.contributor.author | Conroy, Melissa | en |
dc.date.accessioned | 2024-05-24T14:05:49Z | |
dc.date.available | 2024-05-24T14:05:49Z | |
dc.date.issued | 2021 | en |
dc.date.submitted | 2021 | en |
dc.identifier.citation | Melo A.M., Mylod E., Fitzgerald V., Donlon N.E., Murphy, D.M., Foley E.K., Reynolds J.V., Doherty D.G., Lysaght J., Dunne M.R. and M.J. Conroy., Tissue distribution of ?? T cell subsets in oesophageal adenocarcinoma, Clinical Immunology., 2021 | en |
dc.identifier.issn | PMID: 34273585 | en |
dc.identifier.other | Y | en |
dc.description | PUBLISHED | en |
dc.description.abstract | The global obesity epidemic is contributing to increased prevalence of diseases fuelled by chronic inflammation, including cancer. Oesophageal adenocarcinoma (OAC) is an obesity-associated malignancy with increasing prevalence, dismal prognosis, and severely dysregulated immune processes. We previously reported that αβ T cells migrate to omentum and liver in OAC and contribute to inflammation in these tissues. Here, we assessed the tissue distribution and phenotype of gamma/delta (γδ) T cells in the blood, omentum, liver and tumour of OAC patients. Our data show that the Vδ1 and Vδ3 subsets of γδ T cells are most prevalent in omentum and liver of OAC patients. Furthermore, γδ T cells are predominantly pro-inflammatory in these tissues, and co-express IFN-γ and IL-17. Moreover, γδ T cells exhibit cytotoxic capabilities in OAC omentum and liver. This study provides the first indication that γδ T cells contribute to obesity-associated inflammation in OAC and might be exploited therapeutically. | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | Clinical Immunology. | en |
dc.rights | Y | en |
dc.subject | Inflammation; Obesity; Oesophageal adenocarcinoma; Omentum; γδ T cells | en |
dc.title | Tissue distribution of ?? T cell subsets in oesophageal adenocarcinoma | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/meconroy | en |
dc.identifier.rssinternalid | 265966 | en |
dc.identifier.doi | https://doi.org/10.1016/j.clim.2021.108797 | en |
dc.rights.ecaccessrights | openAccess | |
dc.subject.TCDTheme | Cancer | en |
dc.subject.TCDTheme | Immunology, Inflammation & Infection | en |
dc.subject.TCDTag | CANCER | en |
dc.subject.TCDTag | Chronic inflamation | en |
dc.subject.TCDTag | Immune system | en |
dc.subject.TCDTag | Tumour immunology and immunotherapy | en |
dc.identifier.rssuri | https://doi.org/10.1016/j.clim.2021.108797 | |
dc.identifier.orcid_id | 0000-0002-3822-0442 | en |
dc.status.accessible | N | en |
dc.identifier.uri | http://hdl.handle.net/2262/108477 | |